Skip to main content
Screener/Healthcare/Biotechnology

AKTS — Aktis Oncology, Inc.

NASDAQ
$18.61-0.23 (-1.22%)
Small CapUnder $20HealthcareHigh ROE
$0.03
$29.16
$18.40
$19.12
EPS (TTM)$-0.81
P/E Ratio-36.53
Dividend Yield—
Market Cap$1.04B
Volume80K
Prev Close$18.84
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$1.9M-$15.1M$-0.28100.0%-809.5%
Q4 '24$933K-$12.1M$-0.23100.0%-1292.2%
Q1 '25$9.0M-$6.4M$-0.0447.7%-71.1%
Q3 '24$7.5M-$23.3M$-0.264.6%-310.4%
Q2 '24$7.0M-$15.7M$-0.219.7%-223.9%
Q1 '24$7.0M-$20.1M$-0.28-15.5%-287.5%
Q4 '23$8.3M-$17.8M$-0.17-20.4%-213.2%
Q3 '23$7.4M-$15.5M$-0.29-15.2%-211.3%
Get Your Daily Market Recap